Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-069796)

Filing Details

Accession Number:: 0001209191-21-069796
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-15 17:21:43
Reporting Period:: 2021-12-13

Accepted Time:: 2021-12-15 17:21:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1678660	Prelude Therapeutics Inc	PRLD	Pharmaceutical Preparations (2834)	811384762

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1825005	Andrew Combs	C/O Prelude Therapeutics Incorporated 200 Powder Mill Road Wilmington DE 19803	Evp, Head Of Chemistry	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-12-13	4,000	$12.12	264,380	No	4	P	Direct
Common Stock	Acquisiton	2021-12-14	4,000	$11.60	268,380	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.